From: A robust prognostic signature for hormone-positive node-negative breast cancer
Study | GSE | Total samples | ER+/LN-/ untreateda/outcome | Duplicates removed | ER+/HER2-array | 10-year relapse | 10-year no relapse |
---|---|---|---|---|---|---|---|
Desmedt, 2007 [3] | GSE7390 | 198 | 135 | 135 | 116 | 42 | 60 |
Ivshina, 2006 [4] | GSE4922 | 290 | 133 | 2 | 2 | 0 | 2 |
Loi, 2007 [5] | GSE6532 | 327 | 170 | 43 | 40 | 10 | 5 |
Miller, 2005 [6] | GSE3494 | 251 | 132 | 115 | 100 | 30 | 52 |
Schmidt, 2008 [7] | GSE11121 | 200 | 200b | 200 | 155 | 25 | 46 |
Sotiriou, 2006 [8] | GSE2990 | 189 | 113 | 48 | 45 | 12 | 15 |
Symmans, 2010 [9] | GSE17705 | 298 | 175 | 110 | 102 | 12 | 41 |
Wang, 2005 [10] | GSE2034 | 286 | 209 | 209 | 173 | 67 | 29 |
Zhang, 2009 [11] | GSE12093 | 136 | 136 | 136 | 125 | 15 | 24 |
Nine studies | 2,175 | 1403 | 998 | 858 | 213 | 274 |